cdr3.alpha	v.alpha	j.alpha	cdr3.beta	v.beta	d.beta	j.beta	species	mhc.a	mhc.b	mhc.class	antigen.epitope	antigen.gene	antigen.species	reference.id	submitter	method.identification	method.frequency	method.singlecell	method.sequencing	method.verification	meta.study.id	meta.cell.subset	meta.subset.frequency	meta.subject.cohort	meta.subject.id	meta.replica.id	meta.clone.id	meta.epitope.id	meta.tissue	meta.donor.MHC	meta.donor.MHC.method	meta.structure.id	comment	v.alpha.fixed	j.alpha.fixed	v.beta.fixed	j.beta.fixed	v.alpha.end.fixed	j.alpha.start.fixed	v.beta.end.fixed	j.beta.start.fixed	v.alpha.end.old	j.alpha.start.old	v.beta.end.old	j.beta.start.old
			CASSPQTGTGGYGYTFG	TRBV6-5		TRBJ1.2	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.085	healthy, CMV-seropositive	1				PBMC	HLA-A2	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: BV13.1	NA	NA	TRBV18*01	TRBJ1-1*01	-1	-1	16	15	-1	-1	12	17
			CASSPQTGTGGYGYTFG	TRBV6-5		TRBJ1.2	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.07	healthy, CMV-seropositive	2				PBMC	HLA-A2	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: BV13.1	NA	NA	TRBV18*01	TRBJ1-1*01	-1	-1	16	15	-1	-1	12	17
			CASSPLFGTSGGETYYFG	TRBV6-5		TRBJ2.5	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.07	healthy, CMV-seropositive	2				PBMC	HLA-A2	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: BV13.1	NA	NA	TRBV18*01	TRBJ1-1*01	-1	-1	16	16	-1	-1	12	18
			CASSPQTGTGGYGYTFG	TRBV6-5		TRBJ1.2	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.024	healthy, CMV-seropositive	4				PBMC	HLA-A2	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: BV13.1	NA	NA	TRBV18*01	TRBJ1-1*01	-1	-1	16	15	-1	-1	12	17
			CASSPQTGASYGYTFG	TRBV6-5		TRBJ1.2	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.024	healthy, CMV-seropositive	4				PBMC	HLA-A2	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: BV13.1	NA	NA	TRBV18*01	TRBJ1-1*01	-1	-1	16	14	-1	-1	12	16
			CASSLVGGRYGYTFG	TRBV12-3		TRBJ1.2	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.024	healthy, CMV-seropositive	4				PBMC	HLA-A2	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: BV8	NA	NA	TRBV11-1*01	TRBJ1-1*01	-1	-1	16	13	-1	-1	16	15
			CASSPQTGTGGYGYTFG	TRBV6-5		TRBJ1.2	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.017	healthy, CMV-seropositive	5				PBMC	HLA-A2	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: BV13.1	NA	NA	TRBV18*01	TRBJ1-1*01	-1	-1	16	15	-1	-1	12	17
			CASSPATGTIYGYTFG	TRBV6-5		TRBJ1.2	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.017	healthy, CMV-seropositive	5				PBMC	HLA-A2	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: BV13.1	NA	NA	TRBV18*01	TRBJ1-1*01	-1	-1	15	14	-1	-1	12	16
			CASSLTSGSPDTQYFG	TRBV27		TRBJ2.3	HomoSapiens	HLA-A*02:01	B2M	MHCI	NLVPMVATV	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.017	healthy, CMV-seropositive	5				PBMC	HLA-A2	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: BV14	NA	NA	TRBV7-3*01	TRBJ1-1*01	-1	-1	17	14	-1	-1	15	16
			CASSILGVSSYNEQFFG	TRBV7-6		TRBJ2.1	HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.23	healthy, CMV-seropositive	25				PBMC	HLA-A2, HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: BV6.4	NA	NA	TRBV19*01	TRBJ1-1*01	-1	-1	15	15	-1	-1	12	17
			CASSFRDYGRYEQYFG	TRBV7-6		TRBJ2.7	HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.038	healthy, CMV-seropositive	27				PBMC	HLA-A2, HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: BV6.4	NA	NA	TRBV12-1*01	TRBJ1-1*01	-1	-1	15	14	-1	-1	12	16
			CASSILGISSYNEQFFG	TRBV7-6		TRBJ2.1	HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.036000000000000004	healthy, CMV-seropositive	29				PBMC	HLA-A2/HLA-A2, HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: BV6.4	NA	NA	TRBV19*01	TRBJ1-1*01	-1	-1	15	15	-1	-1	12	17
			CASSLGPITEAPFG	TRBV27		TRBJ1.1	HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.059000000000000004	healthy, CMV-seropositive	30				PBMC	HLA-A2, HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: BV14	NA	NA	TRBV13*01	TRBJ1-1*01	-1	-1	17	12	-1	-1	15	14
			CASSPSAQYNEQFFG	TRBV7-6		TRBJ2.1	HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.065	healthy, CMV-seropositive	40				PBMC	HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: BV6.4	NA	NA	TRBV18*01	TRBJ1-1*01	-1	-1	15	13	-1	-1	12	15
			CASSLRGAATDTQYFG	TRBV7-6		TRBJ2.1	HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.065	healthy, CMV-seropositive	40				PBMC	HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: BV6.4	NA	NA	TRBV7-3*01	TRBJ1-1*01	-1	-1	16	14	-1	-1	12	16
			CASTNHDRGGMNTEAPFG	TRBV7-6		TRBJ1.1	HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.073	healthy, CMV-seropositive	41				PBMC	HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: BV6.4	NA	NA	TRBV7-9*05	TRBJ1-1*01	-1	-1	14	16	-1	-1	10	18
			CASSLVGQGLSDEQFFG	TRBV7-6		TRBJ2.1	HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.035	healthy, CMV-seropositive	43				PBMC	HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: BV6.4	NA	NA	TRBV11-1*01	TRBJ1-1*01	-1	-1	16	15	-1	-1	12	17
CATVLRMDSSYKLIFG	TRAV3	TRAJ16.5					HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.23	healthy, CMV-seropositive	25				PBMC	HLA-A2, HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: AV3.1	TRAV17*01	TRAJ4*01	NA	NA	10	13	-1	-1	6	16	-1	-1
CAVRVSMDSSYKLIFG	TRAV16	TRAJ16.5					HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.065	healthy, CMV-seropositive	40				PBMC	HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: AV16.1	TRAV1-1*01	TRAJ4*01	NA	NA	13	13	-1	-1	6	16	-1	-1
CAMREGRDSSYKLIFG	TRAV6	TRAJ16.5					HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.073	healthy, CMV-seropositive	41				PBMC	HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: AV6.1	TRAV14/DV4*01	TRAJ4*01	NA	NA	17	13	-1	-1	6	16	-1	-1
CAVRVSMDSSYKLIFG	TRAV16	TRAJ16.5					HomoSapiens	HLA-B*07:02	B2M	MHCI	TPRVTGGGAM	pp65	CMV	PMID:12165524	Ivan Zvyagin	tetramer-magnetic-selection			sanger			CD8	0.073	healthy, CMV-seropositive	41				PBMC	HLA-B7	Ab, PCR		Ambiguous TRBV nomenclature used. V segment name originally provided in the paper: AV16	TRAV1-1*01	TRAJ4*01	NA	NA	13	13	-1	-1	6	16	-1	-1
